UNIVERSITY OF CHICAGO MEDICINE and Blue Cross and Blue Shield of Illinois launched an oncology intensive medical home program. The UCMedicine IMH will treat qualifying PPO patients receiving chemotherapy for a cancer diagnosis of breast, colon, lung, pancreatic, prostate and non-Hodgkin’s lymphoma. “In conjunction with the oncologists at UCMedicine, we will be utilizing the latest...
Richard Pazdur, FDA’s top oncologist who last week received a battlefield promotion to the role of director of the FDA Center for Drug Evaluation and Research, is described as a stabilizing figure respected by major patient groups, oncology professional societies, and the industry.
